London: Researchers have taken a critical step towards developing a rapid, inexpensive diagnostic method for autism.Presently, there are no acknowledged biomarkers for autism.Through advanced mass spectrometry the researchers at Berzelii Centre and the Science for Life Laboratory in Uppsala, in collaboration with colleagues at Linnaeus University in Sweden and the Faculty of Medicine in Tehran, Iran managed to capture promising biomarkers from a tiny blood sample.Many diseases are caused by protein alterations inside and outside the body’s cells.By studying protein patterns in tissue and body fluids, these alterations can be mapped to provide important information about underlying causes of disease.Sometimes protein patterns can also be used as biomarkers to enable diagnosis or as a prognosticating tool to monitor the development of a disease.In the current study disruptions of the nervous system were in focus when the scientists studied protein patterns in autism spectrum disorder (ASD).To identify potential biomarkers (peptides or proteins), the researchers performed a detailed protein analysis of blood plasma from children with ASD compared with a control group.
Modi critics should go to Pakistan: Giriraj Singh
Modi to file nomination from Varanasi on April 24
FIR registered against Ajit Pawar
Stop govt from appointing new Army chief: BJP to Election Commission